Home/Filings/4/0001235802-19-000076
4//SEC Filing

Asper Jason D. 4

Accession 0001235802-19-000076

CIK 0001492658other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 4:15 PM ET

Size

7.7 KB

Accession

0001235802-19-000076

Insider Transaction Report

Form 4
Period: 2019-07-26
Asper Jason D.
Sr VP, Strategy & Corp. Dev.
Transactions
  • Award

    Stock Option (right to buy)

    2019-07-26+21,29421,294 total
    Exercise: $27.84Exp: 2029-07-26Ordinary Shares (21,294 underlying)
  • Award

    Ordinary Shares, par value EUR 0.03 per share

    2019-07-26+6,92423,128 total
Footnotes (3)
  • [F1]These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
  • [F2]Includes 13,899 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 6,924 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
  • [F3]This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001714435

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:15 PM ET
Size
7.7 KB